Antibiotic Resistance inNeisseria gonorrhoeae
Open Access
- 15 August 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (s4), S263-S268
- https://doi.org/10.1086/430787
Abstract
The incidence of gonorrhea is increasing in developed countries and remains high elsewhere. This untenable disease burden, the complication rate in women and newborns, and the amplification of human immunodeficiency virus transmission that accompanies gonorrhea makes control of gonococcal disease a priority. However, antibiotic resistance in Neisseria gonorrhoeae has severely compromised the successful treatment of gonorrhea. Older therapies are ineffective, whereas those that remain efficacious are unaffordable in many high-incidence settings. Penicillins, tetracyclines, and newer macrolides have limited utility, and spectinomycin (and in many parts of the world, quinolones) have been withdrawn because of resistance. Of the usually recommended treatments, only the third-generation cephalosporins, and most notably ceftriaxone, have retained their efficacy, but decreased susceptibility to these antibiotics has also appeared. A sustained decrease in gonococcal disease requires an integrated approach combining improved prevention, better diagnosis, and effective treatment. Without continued commitment and effort, gonorrhea may well become untreatable.Keywords
This publication has 5 references indexed in Scilit:
- Increasing gonorrhoea reports--not only in London.The Lancet, 2000
- Continuing Evolution of the Pattern of Quinolone Resistance in Neisseria gonorrhoeae Isolated in Sydney, AustraliaSexually Transmitted Diseases, 1998
- Sexually transmitted diseases enhance HIV transmission: no longer a hypothesisThe Lancet, 1998
- Ethnicity and sexually transmitted infectionsCurrent Opinion in Infectious Diseases, 1998
- Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1The Lancet, 1997